Literature DB >> 18297472

Background noise of infection for using ANCA as a diagnostic tool for vasculitis in tropical and developing countries.

Kanjaksha Ghosh1, Vandana Pradhan, Kinjalka Ghosh.   

Abstract

Antineutrophil cytoplasmic antibody (ANCA) is often used in the laboratory to confirm paucicellular vasculitis like Wegener's granulomatosis, Churg Strauss syndrome or polyarteritis nodosa in the presence of suggestive clinical features. In tropical countries, tuberculosis, leprosy and, occasionally, malaria can produce clinical features similar to a vasculitic illness and all the three infections are known to be associated with auto antibodies. We tested 318 patients suffering from malaria, tuberculosis or leprosy for ANCA positivity. ANCA positivity was found in 19%, 32% and 30% of malaria, tuberculosis and leprosy patients (Pradhan V, Badakere S, Shankarkumar V, Iyer Y, Ghosh K, Karnad D, Indian J Malariol, 39:51-59, 2002; Pradhan V, Badakere S, Ghosh K, Pawar A, Indian J Med Sci, 58:283-288, 2004a; Pradhan V, Badakere S, Shankarkumar V, Lepr Rev, 75:50-56, 2004b), respectively, raising the possibility that ANCA positivity with clinical features suggestive of vasculitis in tropical countries may even be related to the background noise of this seropositivity caused by one of these three infections rather than confirming the diagnosis of paucicellular vasculitis. Hence, one should be careful about the background noise of ANCA positivity caused by these infections while diagnosing a vasculitic illness.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18297472     DOI: 10.1007/s00436-008-0929-0

Source DB:  PubMed          Journal:  Parasitol Res        ISSN: 0932-0113            Impact factor:   2.289


  17 in total

1.  Use of immunofluorescence and confocal laser scanning microscopy in identifying rare cases of anti-neutrophil cytoplasmic antibodies (ANCA) showing dual specificities to myeloperoxidase and proteinase3.

Authors:  S S Badakere; Vandana D Pradhan; A F Almeida; Aruna R Pawar
Journal:  J Fluoresc       Date:  2004-07       Impact factor: 2.217

2.  Detection of anti-neutrophil cytoplasmic antibodies after acute Plasmodium falciparum malaria.

Authors:  C Wenisch; H Wenisch; H C Bankl; M Exner; W Graninger; S Looareesuwan; H Rumpold
Journal:  Clin Diagn Lab Immunol       Date:  1996-01

Review 3.  Antineutrophil cytoplasmic autoantibodies: a review of the antigens involved, the assays, and the clinical and possible pathogenetic consequences.

Authors:  E C Hagen; B E Ballieux; L A van Es; M R Daha; F J van der Woude
Journal:  Blood       Date:  1993-04-15       Impact factor: 22.113

4.  Autoantibodies in malaria, tuberculosis and hepatitis B in a west African population.

Authors:  A O Adebajo; P Charles; R N Maini; B L Hazleman
Journal:  Clin Exp Immunol       Date:  1993-04       Impact factor: 4.330

5.  Diagnostic value of standardized assays for anti-neutrophil cytoplasmic antibodies in idiopathic systemic vasculitis. EC/BCR Project for ANCA Assay Standardization.

Authors:  E C Hagen; M R Daha; J Hermans; K Andrassy; E Csernok; G Gaskin; P Lesavre; J Lüdemann; N Rasmussen; R A Sinico; A Wiik; F J van der Woude
Journal:  Kidney Int       Date:  1998-03       Impact factor: 10.612

6.  Anti-neutrophil cytoplasmic antibodies (ANCA) in malaria.

Authors:  Vandana Pradhan; S S Badakere; U Shankarkumar; Y S Iyer; K Ghosh; D Karnad
Journal:  Indian J Malariol       Date:  2002 Sep-Dec

7.  Benign cutaneous polyarteritis nodosa in children below 10 years of age--a clinical experience.

Authors:  L Kumar; B R Thapa; B Sarkar; B N Walia
Journal:  Ann Rheum Dis       Date:  1995-02       Impact factor: 19.103

8.  A study of anti-neutrophil cytoplasm antibodies in systemic vasculitis and other related disorders.

Authors:  V D Pradhan; S S Badakere; Y S Iyer; R Kumar; A F Almeida
Journal:  J Postgrad Med       Date:  2003 Jan-Mar       Impact factor: 1.476

9.  Low seroprevalence and poor specificity of antineutrophil cytoplasmic antibodies in tuberculosis.

Authors:  L Teixeira; A Mahr; F Jaureguy; L-H Noël; H Nunes; A Lefort; S Barry; P Deny; L Guillevin
Journal:  Rheumatology (Oxford)       Date:  2004-11-16       Impact factor: 7.580

10.  ANCA: serology in Wegener's granulomatosis.

Authors:  Vandana D Pradhan; S S Badakere; K Ghosh; A Almeida
Journal:  Indian J Med Sci       Date:  2005-07
View more
  4 in total

1.  Anti-PR3 and anti-MPO antibodies are not present in sera of patients with pulmonary tuberculosis.

Authors:  I Lima; R C Oliveira; M S Cabral; A Atta; S Marchi; E Reis; M G Reis; L Barbosa; M B Santiago
Journal:  Rheumatol Int       Date:  2014-04-10       Impact factor: 2.631

2.  The effect of anti-tuberculosis treatment on levels of anti-phospholipid and anti-neutrophil cytoplasmatic antibodies in patients with active tuberculosis.

Authors:  Ori Elkayam; Daniele Bendayan; Refael Segal; Yinon Shapira; Boris Gilburd; Sandra Reuter; Nancy Agmon-Levin; Yehuda Shoenfeld
Journal:  Rheumatol Int       Date:  2012-08-04       Impact factor: 3.580

Review 3.  Glomerular disease in patients with infectious processes developing antineutrophil cytoplasmic antibodies.

Authors:  Konstantin N Konstantinov; Suzanne N Emil; Marc Barry; Susan Kellie; Antonios H Tzamaloukas
Journal:  ISRN Nephrol       Date:  2013-02-19

Review 4.  Recent advances in anti-neutrophil cytoplasmic antibody-associated vasculitis.

Authors:  B Lazarus; G T John; C O'Callaghan; D Ranganathan
Journal:  Indian J Nephrol       Date:  2016 Mar-Apr
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.